Skip to content

Clinical trials

Phase 1 Infections trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Infections Phase: Phase 1 Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20181
20202
20221
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CanSino Biologics Inc.2
Sinovac Biotech Co., Ltd2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Qilu Pharmaceutical Co., Ltd.1
Suzhou Erye Pharmaceutical Co., Ltd.1
Tasly Tianjin Biopharmaceutical Co., Ltd.1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Infections9
Enterovirus Infections2
Anemia1
COVID-191
Diphtheria1
Hand, Foot and Mouth Disease1
Hemorrhage1
Hepatitis B1
Leukemia, Myeloid, Acute1
Neutropenia1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.